Hayat, M. J., Howlader, N., Reichman, M. E. & Edwards, B. K. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12, 20–37 (2007).
Google ScholarÂ
Kantarjian, H. Acute myeloid leukemia–major progress over four decades and glimpses into the future. Am. J. Hematol. 91, 131–145 (2016).
Google ScholarÂ
Nwosu, G. O., Ross, D. M., Powell, J. A. & Pitson, S. M. Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia. Cell Death Dis. 15, 413 (2024).
Google ScholarÂ
Hildebrand, F. L. Jr., Rosenow, E. C. III., Habermann, T. M. & Tazelaar, H. D. Pulmonary complications of leukemia. Chest 98, 1233–1239 (1990).
Google ScholarÂ
Azoulay, E. et al. Acute monocytic leukemia presenting as acute respiratory failure. Am. J. Respir. Crit. Care Med. 167, 1329–1333 (2003).
Google ScholarÂ
Kovalski, R., Hansen-Flaschen, J., Lodato, R. F. & Pietra, G. G. Localized leukemic pulmonary infiltrates. Diagnosis by bronchoscopy and resolution with therapy. Chest 97, 674–678 (1990).
Google ScholarÂ
Bodey, G. P., Powell, R. D. Jr., Hersh, E. M., Yeterian, A. & Freireich, E. J. Pulmonary complications of acute leukemia. Cancer 19, 781–793 (1966).
Google ScholarÂ
Tettamanti, S., Pievani, A., Biondi, A., Dotti, G. & Serafini, M. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia 36, 13–22 (2022).
Google ScholarÂ
Baryawno, N. et al. A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. Cell 177, 1915–1932 e1916 (2019).
Google ScholarÂ
van Galen, P. et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176, 1265–1281 e1224 (2019).
Google ScholarÂ
Lasry, A. et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat. Cancer 4, 27–42 (2023).
Google ScholarÂ
Ye, H. et al. The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG. Cancer Discov. 11, 500–519 (2021).
Google ScholarÂ
Sandhow, L. et al. Skin mesenchymal niches maintain and protect AML-initiating stem cells. J. Exp. Med. 220, e20220953 (2023).
Google ScholarÂ
Vasilatou, D. et al. CNS involvement in AML patient treated with 5-azacytidine. Case Rep. Hematol. 2014, 937203 (2014).
Google ScholarÂ
Travaglini, K. J. et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature 587, 619–625 (2020).
Google ScholarÂ
Zilionis, R. et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50, 1317–1334 e1310 (2019).
Google ScholarÂ
Melms, J. C. et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114–119 (2021).
Google ScholarÂ
Yang, R. Y., Rabinovich, G. A. & Liu, F. T. Galectins: structure, function and therapeutic potential. Expert Rev. Mol. Med. 10, e17 (2008).
Google ScholarÂ
Rossi, G. A., Balbi, B., Risso, M., Repetto, M. & Ravazzoni, C. Acute myelomonocytic leukemia. Demonstration of pulmonary involvement by bronchoalveolar lavage. Chest 87, 259–260 (1985).
Google ScholarÂ
Passaro, D. et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell 32, 324–341 e326 (2017).
Google ScholarÂ
Umbrello, M., Marino, A. & Chiumello, D. Tidal volume in acute respiratory distress syndrome: how best to select it. Ann. Transl. Med. 5, 287 (2017).
Google ScholarÂ
Gillich, A. et al. Capillary cell-type specialization in the alveolus. Nature 586, 785–789 (2020).
Google ScholarÂ
Corradi, G. et al. Release of IFNγ by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T Cells. Clin. Cancer Res. 28, 3141–3155 (2022).
Google ScholarÂ
Hong, C. et al. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature 607, 366–373 (2022).
Google ScholarÂ
Yeaton, A. et al. The impact of inflammation-induced tumor plasticity during myeloid transformation. Cancer Discov. 12, 2392–2413 (2022).
Google ScholarÂ
Villar, J. et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir. Med. 8, 267–276 (2020).
Google ScholarÂ
Allen, J. Acute eosinophilic pneumonia. Semin. Respir. Crit. Care Med. 27, 142–147 (2006).
Google ScholarÂ
Azoulay, E. et al. Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur. Respir. J. 39, 648–653 (2012).
Google ScholarÂ
de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374–403 (2023).
Google ScholarÂ
Narasimhan, P. B., Marcovecchio, P., Hamers, A. A. J. & Hedrick, C. C. Nonclassical monocytes in health and disease. Annu. Rev. Immunol. 37, 439–456 (2019).
Google ScholarÂ
Huang, J. et al. Role of CD47 in tumor immunity: a potential target for combination therapy. Sci Rep. 12, 9803 (2022).
Google ScholarÂ
Dixon, K. O. et al. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature 595, 101–106 (2021).
Google ScholarÂ
Chen, S., Zhang, S., Chen, S. & Ma, F. The prognostic value and immunological role of CD44 in pan-cancer study. Sci Rep. 13, 7011 (2023).
Google ScholarÂ
Mascarenhas, J. et al. A phase Ib trial of AVID200, a TGFβ 1/3 Trap, in patients with myelofibrosis. Clin. Cancer Res. 29, 3622–3632 (2023).
Google ScholarÂ
Rodriguez-Sevilla, J. J. et al. The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial. Nat. Commun. 15, 9840 (2024).
Google ScholarÂ
Sheng, F. et al. IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential. Front. Immunol. 16, 1533335 (2025).
Google ScholarÂ
Zheng, S. et al. Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity. Int. J. Biol. Sci. 19, 981–993 (2023).
Google ScholarÂ
Choukrani, G. et al. Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance. Cell Death Discov. 9, 228 (2023).
Google ScholarÂ
Lv, Y., Ma, X., Ma, Y., Du, Y. & Feng, J. A new emerging target in cancer immunotherapy: galectin-9 (LGALS9). Genes Dis. 10, 2366–2382 (2023).
Google ScholarÂ
Wang, Y. et al. IL-33/IL1RL1 axis regulates cell survival through the p38 MAPK pathway in acute myeloid leukemia. Leuk. Res. 96, 106409 (2020).
Google ScholarÂ
Naef, P. et al. IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. Sci. Signal. 16, eadd7705 (2023).
Google ScholarÂ
Fu, D. et al. Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway. Nat. Commun. 16, 6369 (2025).
Google ScholarÂ
Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556–W560 (2019).
Google ScholarÂ
Gieseke, F. et al. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation. Eur. J. Immunol. 43, 2741–2749 (2013).
Google ScholarÂ
Dolgalev, I. et al. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma. Nat. Commun. 14, 6764 (2023).
Google ScholarÂ
Yang, R. et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat. Commun. 12, 832 (2021).
Google ScholarÂ
Jiang, H. et al. ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche. Nat. Commun. 16, 6580 (2025).
Google ScholarÂ
Wechsler, M. E. et al. Efficacy and safety of itepekimab in patients with moderate-to-severe asthma. N. Engl. J. Med. 385, 1656–1668 (2021).
Google ScholarÂ
Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).
Google ScholarÂ
Filipovic, A. et al. A phase I dose escalation and expansion trial of Lyt-200 (a first-in-class anti-galectin-9 antibody) alone and in combination with venetoclax/HMA in relapsed/refractory AML/MDS. Blood 144, 1499 (2024).
Google ScholarÂ
Alva, J. A. et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev. Dyn. 235, 759–767 (2006).
Google ScholarÂ
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
Google ScholarÂ
Loberg, M. A. et al. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis. Leukemia 33, 1635–1649 (2019).
Google ScholarÂ
Glytsou, C. et al. Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia. Cancer Discov. 13, 1656–1677 (2023).
Google ScholarÂ
Loizou, E. et al. A gain-of-function p53-mutant oncogene promotes cell fate plasticity and myeloid leukemia through the pluripotency factor FOXH1. Cancer Discov. 9, 962–979 (2019).
Google ScholarÂ
Daley, D. et al. γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation. Cell 166, 1485–1499 e1415 (2016).
Google ScholarÂ
Quattrocelli, M. et al. Intermittent prednisone treatment in mice promotes exercise tolerance in obesity through adiponectin. J. Exp. Med. 219, e20211906 (2022).
Google ScholarÂ
Ural, B. B. et al. Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties. Sci. Immunol. 5, eaax8756 (2020).
Google ScholarÂ
Dolgalev, I. Seq-N-Slide. Zenodo https://doi.org/10.5281/zenodo.5550459 (2025).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Google ScholarÂ
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 e3529 (2021).
Google ScholarÂ
Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401 (2014).
Google ScholarÂ
Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).
Google ScholarÂ
Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484–1506 (2020).
Google ScholarÂ
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Google ScholarÂ
Chu, T., Wang, Z., Pe’er, D. & Danko, C. G. Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat. Cancer 3, 505–517 (2022).
Google ScholarÂ
Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293–304 (2024).
Google ScholarÂ
Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol. 40, 517–526 (2022).
Google ScholarÂ
Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med. 29, 1563–1577 (2023).
Google ScholarÂ
Paraskevopoulou, V. et al. Processed Seurat objects for AML lung infiltration and respiratory failure. Zenodo. https://doi.org/10.5281/zenodo.20274428 (2026).
